Curevo Vaccine logo

Curevo Vaccine Employee Directory

Biotechnology ResearchWashington, United States11-50 Employees

Curevo Vaccine is a biotechnology research company that operates as a clinical-stage developer of vaccines targeting varicella and herpes zoster. It is headquartered in Bothell, Washington, at 21540 30th Drive Southeast, Suite 260, United States. Its lead product candidate, amezosvatein (CRV-101), is an adjuvanted subunit vaccine designed to prevent herpes zoster, with aims of non-inferior efficacy and improved reactogenicity relative to Shingrix. The company employs between 11 and 50 people. In May 2026, Eli Lilly acquired Curevo Vaccine for about $1.5 billion, marking a major development in the company's history.

Find Curevo Vaccine employees' phone numbers or email addresses

Curevo Vaccine Global Highlights

Location
Employees

North America
47

Minus sign iconPlus sign icon
  • United States Of America
    47

Asia
1

Minus sign iconPlus sign icon
  • India
    1

Europe
1

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    1

Curevo Vaccine's Leadership

  • Controller at Curevo Vaccine
    F. H.
    Controller
  • Development Director, Clinical Operations at Curevo Vaccine
    M. C.
    Development Director, Clinical Operations
  • Senior Program Manager at Curevo Vaccine
    M. S.
    Senior Program Manager
  • Senior Cmc Manager For Vaccine Adjuvant at Curevo Vaccine
    Y. X.
    Senior Cmc Manager For Vaccine Adjuvant
  • Principal at Curevo Vaccine
    J. B.
    Principal
  • General Counsel at Curevo Vaccine
    J. B.
    General Counsel

Curevo Vaccine Employee Metrics

100%
50%
0%
2026
2025
  • Program & Project Management
  • Administrative
  • Biotechnology
  • Legal
  • Accounting
  • Other
  • Business
  • Entrepreneurship
  • Quality Assurance

Contact profiles from Curevo Vaccine

Name
Title
Contact
Location
Last Update
  • Controller at Curevo Vaccine
    F. H.
    Controller
    Oct 18, 2024
  • Development Director, Clinical Operations at Curevo Vaccine
    M. C.
    Development Director, Clinical Operations
    Oct 18, 2024
  • Senior Program Manager at Curevo Vaccine
    M. S.
    Senior Program Manager
    Feb 28, 2026
  • Senior Cmc Manager For Vaccine Adjuvant at Curevo Vaccine
    Y. X.
    Senior Cmc Manager For Vaccine Adjuvant
    Oct 23, 2024
  • Principal at Curevo Vaccine
    J. B.
    Principal
    Oct 17, 2024
  • General Counsel at Curevo Vaccine
    J. B.
    General Counsel
    Oct 18, 2024

Frequently Asked Questions

What is Curevo Vaccine known for?

Minus sign iconPlus sign icon
Curevo Vaccine was founded in 2017 and operates in the Biotechnology Research industry. Explore Curevo Vaccine's company overview page for more information.

What is Curevo Vaccine's most common email format?

Minus sign iconPlus sign icon
Curevo Vaccine employees' email format typically follows the pattern of First.Last@curevovaccine.com. Trying to find reliable and up-to-date employee contact data? Find more Curevo Vaccine email formats with LeadIQ.

How many employees does Curevo Vaccine have currently?

Minus sign iconPlus sign icon
Curevo Vaccine has approximately 43 employees as of August 2026. These team members are located across 3 continents, including North America, Asia and Europe.

Who are Curevo Vaccine's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Curevo Vaccine's key employees include:

  • Controller: F. H.
  • Development Director, Clinical Operations: M. C.
  • Senior Program Manager: M. S.
  • Senior Cmc Manager For Vaccine Adjuvant: Y. X.
  • Principal: J. B.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.